Correlation Between ScinoPharm Taiwan and SciVision Biotech
Can any of the company-specific risk be diversified away by investing in both ScinoPharm Taiwan and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ScinoPharm Taiwan and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ScinoPharm Taiwan and SciVision Biotech, you can compare the effects of market volatilities on ScinoPharm Taiwan and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ScinoPharm Taiwan with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ScinoPharm Taiwan and SciVision Biotech.
Diversification Opportunities for ScinoPharm Taiwan and SciVision Biotech
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ScinoPharm and SciVision is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding ScinoPharm Taiwan and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and ScinoPharm Taiwan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ScinoPharm Taiwan are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of ScinoPharm Taiwan i.e., ScinoPharm Taiwan and SciVision Biotech go up and down completely randomly.
Pair Corralation between ScinoPharm Taiwan and SciVision Biotech
Assuming the 90 days trading horizon ScinoPharm Taiwan is expected to generate 0.36 times more return on investment than SciVision Biotech. However, ScinoPharm Taiwan is 2.75 times less risky than SciVision Biotech. It trades about -0.16 of its potential returns per unit of risk. SciVision Biotech is currently generating about -0.19 per unit of risk. If you would invest 2,410 in ScinoPharm Taiwan on August 30, 2024 and sell it today you would lose (75.00) from holding ScinoPharm Taiwan or give up 3.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.65% |
| Values | Daily Returns |
ScinoPharm Taiwan vs. SciVision Biotech
Performance |
| Timeline |
| ScinoPharm Taiwan |
| SciVision Biotech |
ScinoPharm Taiwan and SciVision Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ScinoPharm Taiwan and SciVision Biotech
The main advantage of trading using opposite ScinoPharm Taiwan and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ScinoPharm Taiwan position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.| ScinoPharm Taiwan vs. Sinphar Pharmaceutical Co | ScinoPharm Taiwan vs. Grape King Bio | ScinoPharm Taiwan vs. Apex Biotechnology Corp | ScinoPharm Taiwan vs. Leatec Fine Ceramics |
| SciVision Biotech vs. Maxigen Biotech | SciVision Biotech vs. Chunghwa Chemical Synthesis | SciVision Biotech vs. Sinphar Pharmaceutical Co | SciVision Biotech vs. ScinoPharm Taiwan |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |